Search results
Vertex is a biotechnology company that develops and commercializes drugs for serious diseases. Learn about its latest news, acquisitions, financial results, corporate responsibility and pain program.
- Our Company
Vertex Pharmaceuticals strikes at the core of serious...
- Our Science
Vertex Forward: Illustrating Our Scientific Strategy A...
- Medicines
Vertex’s Inclusion, Diversity and Equity Priorities Our...
- Patients
Creating transformative medicines truly takes a village....
- Responsibility
At Vertex, giving back includes providing opportunities to...
- News
Vertex Announces Positive Results From Ongoing Phase 1/2...
- Investors
The Investor Relations website contains information about...
- Our Company
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex is a biopharmaceutical company that creates transformative medicines for people with serious diseases. Learn about their mission, values, culture, R&D and recognition.
Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Vertex is a biotechnology company focused on developing and commercializing treatments for serious diseases. Find out its latest financial results, events, presentations, and stock information.
Find out the latest news and updates from Vertex, a global biotechnology company focused on cystic fibrosis, pain and immunology. Read about its financial results, product approvals, collaborations, and leadership changes.
Jan 30, 2024 · Vertex announces positive results from Phase 3 program for VX-548, a selective NaV1.8 inhibitor for moderate-to-severe acute pain. VX-548 showed statistically significant improvement in pain compared to placebo and was safe and well tolerated in surgical and non-surgical pain conditions.